Research case studies Explore a selection of reports that spotlight particular areas of research at the Crick over the past five years.
Vacancies Find links to current vacancies, and information about recruitment to various types of role.
Coronavirus (COVID-19) research Crick researchers are working at the forefront of the scientific response to answer some of the most urgent questions about the SARS-CoV-2 pathogen, from how we can improve testing, to why it’s deadly in some people but causes no symptoms in others.
Breadcrumb Research Topics Biochemistry & Proteomics Equipment in the Mass Spectrometry Proteomics Science Technology Platform. Toggle to view hero caption IntroA wide variety of biochemical and proteomic approaches are used to understand the complex molecules and their interactions underlying the biological processes at work in our cells and tissues. Research groups Dimitrios Anastasiou Cancer Metabolism Laboratory David Balchin Protein Biogenesis Laboratory Kate Bishop Retroviral Replication Laboratory Mike Blackman Malaria Biochemistry Laboratory Simon Boulton DSB Repair Metabolism Laboratory Luiz Pedro Carvalho Mycobacterial Metabolism and Antibiotic Research Laboratory Peter Cherepanov Chromatin structure and mobile DNA Laboratory Alessandro Costa Macromolecular Machines Laboratory Bart de Strooper | Lorena Arancibia Cellular Phase of Alzheimer’s Disease Laboratory John Diffley Chromosome Replication Laboratory Radoslav Enchev Visual Biochemistry Laboratory Fermentation Sergi Garcia Manyes Single Molecule Mechanobiology Laboratory Jeannine Hess Biological Inorganic Chemistry Laboratory Neil McDonald Signalling and Structural Biology Laboratory Charlie McTernan Artificial Molecular Machinery Laboratory Michele Mishto Molecular Immunology lab Paul Nurse Cell Cycle Laboratory Peter Parker Protein Phosphorylation Laboratory Peter Ratcliffe Hypoxia Biology Laboratory Pagination Current page 1 Page 2 Next page Next Last page Last Science Technology Platforms Metabolomics Proteomics Related content Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery Type: News 2 April 2021 New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery Type: News 25 March 2021 Ancient viruses could help kill cancers Type: News 20 September 2019 Novel CRISPR method identifies key genes for Toxoplasma survival Type: News 3 September 2019 Share the page Share on Twitter Share on Facebook Share on LinkedIn Share on Email
Francis Crick Institute and GSK to pioneer reactive fragment screening in drug discovery Type: News 2 April 2021
New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery Type: News 25 March 2021
